A citation-based method for searching scientific literature

Edward J Saunders, Zsofia Kote-Jarai, Rosalind A Eeles. Cancers (Basel) 2021
Times Cited: 7







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
David V Conti, Burcu F Darst, Lilit C Moss, Edward J Saunders, Xin Sheng, Alisha Chou, Fredrick R Schumacher, Ali Amin Al Olama, Sara Benlloch, Tokhir Dadaev,[...]. Nat Genet 2021
37
57

A Review of Prostate Cancer Genome-Wide Association Studies (GWAS).
Sarah Benafif, Zsofia Kote-Jarai, Rosalind A Eeles. Cancer Epidemiol Biomarkers Prev 2018
57
42

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
371
42

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Fredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, Sara Benlloch, Mahbubl Ahmed, Edward J Saunders, Tokhir Dadaev, Daniel Leongamornlert, Ezequiel Anokian, Clara Cieza-Borrella,[...]. Nat Genet 2018
263
42

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Tokhir Dadaev, Edward J Saunders, Paul J Newcombe, Ezequiel Anokian, Daniel A Leongamornlert, Mark N Brook, Clara Cieza-Borrella, Martina Mijuskovic, Sarah Wakerell, Ali Amin Al Olama,[...]. Nat Commun 2018
54
42

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.
Lorelei A Mucci, Jacob B Hjelmborg, Jennifer R Harris, Kamila Czene, David J Havelick, Thomas Scheike, Rebecca E Graff, Klaus Holst, Sören Möller, Robert H Unger,[...]. JAMA 2016
329
42

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Veda N Giri, Karen E Knudsen, William K Kelly, Wassim Abida, Gerald L Andriole, Chris H Bangma, Justin E Bekelman, Mitchell C Benson, Amie Blanco, Arthur Burnett,[...]. J Clin Oncol 2018
99
42

Germ-line mutations in mismatch repair genes associated with prostate cancer.
Eli Marie Grindedal, Pål Møller, Ros Eeles, Astrid Tenden Stormorken, Inger Marie Bowitz-Lothe, Stefan Magnus Landrø, Neal Clark, Rune Kvåle, Susan Shanley, Lovise Maehle. Cancer Epidemiol Biomarkers Prev 2009
77
42

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Elizabeth C Page, Elizabeth K Bancroft, Mark N Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh,[...]. Eur Urol 2019
63
42

High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.
Peng Zhang, Ji-Han Xia, Jing Zhu, Ping Gao, Yi-Jun Tian, Meijun Du, Yong-Chen Guo, Sufyan Suleman, Qin Zhang, Manish Kohli,[...]. Nat Commun 2018
24
28

A genomic and epigenomic atlas of prostate cancer in Asian populations.
Jing Li, Chuanliang Xu, Hyung Joo Lee, Shancheng Ren, Xiaoyuan Zi, Zhiming Zhang, Haifeng Wang, Yongwei Yu, Chenghua Yang, Xiaofeng Gao,[...]. Nature 2020
51
28

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
28

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
Questa Karlsson, Mark N Brook, Tokhir Dadaev, Sarah Wakerell, Edward J Saunders, Kenneth Muir, David E Neal, Graham G Giles, Robert J MacInnis, Stephen N Thibodeau,[...]. Eur Urol Oncol 2021
6
33

Natural history and imaging in men with high genetic risk for developing prostate cancer.
William L Dahut, Anna Couvillon, Peter A Pinto, Baris Turkbey, Fatima Karzai. Can J Urol 2019
2
100

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
506
28

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Mev Dominguez-Valentin, Patrick Joost, Christina Therkildsen, Mats Jonsson, Eva Rambech, Mef Nilbert. BMC Urol 2016
40
28

Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.
Shae Ryan, Mark A Jenkins, Aung Ko Win. Cancer Epidemiol Biomarkers Prev 2014
72
28

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Daniel A Leongamornlert, Edward J Saunders, Sarah Wakerell, Ian Whitmore, Tokhir Dadaev, Clara Cieza-Borrella, Sarah Benafif, Mark N Brook, Jenny L Donovan, Freddie C Hamdy,[...]. Eur Urol 2019
29
28


Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014
155
28

High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry.
Christophe Rosty, Michael D Walsh, Noralane M Lindor, Stephen N Thibodeau, Erin Mundt, Steven Gallinger, Melyssa Aronson, Aaron Pollett, John A Baron, Sally Pearson,[...]. Fam Cancer 2014
34
28

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Liisa Määttänen, Hans Lilja,[...]. Lancet 2014
833
28

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
176
28

The spectrum of urological malignancy in Lynch syndrome.
P J Barrow, S Ingham, C O'Hara, K Green, I McIntyre, F Lalloo, J Hill, D G Evans. Fam Cancer 2013
30
28

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
Aung Ko Win, Noralane M Lindor, Joanne P Young, Finlay A Macrae, Graeme P Young, Elizabeth Williamson, Susan Parry, Jack Goldblatt, Lara Lipton, Ingrid Winship,[...]. J Natl Cancer Inst 2012
133
28

Prostate cancer incidence in males with Lynch syndrome.
Sigurdis Haraldsdottir, Heather Hampel, Lai Wei, Christina Wu, Wendy Frankel, Tanios Bekaii-Saab, Albert de la Chapelle, Richard M Goldberg. Genet Med 2014
66
28

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
28

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
394
28

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.
Tommy Nyberg, Debra Frost, Daniel Barrowdale, D Gareth Evans, Elizabeth Bancroft, Julian Adlard, Munaza Ahmed, Julian Barwell, Angela F Brady, Carole Brewer,[...]. Eur Urol 2020
40
28

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study.
Ola Bratt, Linda Drevin, Olof Akre, Hans Garmo, Pär Stattin. J Natl Cancer Inst 2016
39
28

Familial prostate cancer: a different disease?
P A Kupelian, E A Klein, J S Witte, V A Kupelian, J H Suh. J Urol 1997
50
28

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan. PLoS Med 2019
23
28

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Henrik Grönberg, Jan Adolfsson, Markus Aly, Tobias Nordström, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Mark Clements,[...]. Lancet Oncol 2015
200
28

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.
Elena Castro, Chee Goh, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Steve Ellis, Debra Frost,[...]. Eur Urol 2015
176
28

Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.
Yishuo Wu, Hongjie Yu, Shuwei Li, Kathleen Wiley, S Lilly Zheng, Holly LaDuca, Marta Gielzak, Rong Na, Brice A J Sarver, Brian T Helfand,[...]. Eur Urol Oncol 2020
17
28

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Mark M Pomerantz, Sandor Spisák, Li Jia, Angel M Cronin, Istvan Csabai, Elisa Ledet, A Oliver Sartor, Irene Rainville, Edward P O'Connor, Zachary T Herbert,[...]. Cancer 2017
130
28

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.
Zafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, Pasquale Rescigno, Wei Yuan, Suzanne Carreira, Maialen Barrero, Antonella Petremolo, Susana Miranda, Ruth Riisnaes,[...]. Eur Urol 2019
44
28


Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.
D Leongamornlert, E Saunders, T Dadaev, M Tymrakiewicz, C Goh, S Jugurnauth-Little, I Kozarewa, K Fenwick, I Assiotis, D Barrowdale,[...]. Br J Cancer 2014
79
28

Genetic testing for hereditary prostate cancer: Current status and limitations.
Jun Tu Zhen, Jamil Syed, Kevin Anh Nguyen, Michael S Leapman, Neeraj Agarwal, Karina Brierley, Xavier Llor, Erin Hofstatter, Brian Shuch. Cancer 2018
32
28

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
28

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
Elena Castro, Christos Mikropoulos, Elizabeth K Bancroft, Tokhir Dadaev, Chee Goh, Natalie Taylor, Edward Saunders, Nigel Borley, Diana Keating, Elizabeth C Page,[...]. Oncologist 2016
25
28

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
699
28

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Jiao Yuan, Kevin H Kensler, Zhongyi Hu, Youyou Zhang, Tianli Zhang, Junjie Jiang, Mu Xu, Yutian Pan, Meixiao Long, Kathleen T Montone,[...]. PLoS Genet 2020
26
14

A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
Burcu F Darst, Peggy Wan, Xin Sheng, Jeannette T Bensen, Sue A Ingles, Benjamin A Rybicki, Barbara Nemesure, Esther M John, Jay H Fowke, Victoria L Stevens,[...]. Eur Urol 2020
11
14

Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression.
Dong Han, Jude N Owiredu, Bridget M Healy, Muqing Li, Maryam Labaf, Jocelyn S Steinfeld, Susan Patalano, Shuai Gao, Mingyu Liu, Jill A Macoska,[...]. Cancer Res 2021
2
50

Cancer health disparities in racial/ethnic minorities in the United States.
Valentina A Zavala, Paige M Bracci, John M Carethers, Luis Carvajal-Carmona, Nicole B Coggins, Marcia R Cruz-Correa, Melissa Davis, Adam J de Smith, Julie Dutil, Jane C Figueiredo,[...]. Br J Cancer 2021
70
14

Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
Yusuke Koga, Hanbing Song, Zachary R Chalmers, Justin Newberg, Eejung Kim, Jian Carrot-Zhang, Daphnee Piou, Paz Polak, Sarki A Abdulkadir, Elad Ziv,[...]. Clin Cancer Res 2020
22
14

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.
Cindy Ke Zhou, Denise Young, Edward D Yeboah, Sally B Coburn, Yao Tettey, Richard B Biritwum, Andrew A Adjei, Evelyn Tay, Shelley Niwa, Ann Truelove,[...]. Am J Epidemiol 2017
35
14

Integrative analysis of 111 reference human epigenomes.
Anshul Kundaje, Wouter Meuleman, Jason Ernst, Misha Bilenky, Angela Yen, Alireza Heravi-Moussavi, Pouya Kheradpour, Zhizhuo Zhang, Jianrong Wang, Michael J Ziller,[...]. Nature 2015
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.